• SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

    Источник: Nasdaq GlobeNewswire / 05 июн 2024 07:00:52   America/New_York

    STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference, taking place in Miami, Florida on Tuesday, June 11, 2024 at 2:00 p.m. ET.

    To access the live webcast, please visit the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference.

    About SpringWorks Therapeutics

    SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. OGSIVEO® (nirogacestat), approved in the United States for the treatment of adult patients with progressing desmoid tumors who require systemic treatment, is the Company’s first FDA-approved therapy. SpringWorks also has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs ranging from preclinical development through advanced clinical trials. In addition to its wholly owned programs, SpringWorks has also entered into multiple collaborations with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients in need.

    For more information, visit www.springworkstx.com and follow @SpringWorksTx on X (formerly Twitter), LinkedIn, and YouTube.

    Contacts:
    Kim Diamond
    Vice President, Communications and Investor Relations 
    Phone: 203-561-1646
    Email: kdiamond@springworkstx.com  

    Samantha Hilson Sandler 
    Senior Director, Investor Relations 
    Phone: 203-461-5501 
    Email: samantha.sandler@springworkstx.com 


    Primary Logo

Опубликовать